MedNet Solutions Recognized as one of the Fastest Growing US Companies
MedNet Solutions Recognized as one of the Fastest Growing US Companies
MINNETONKA, MN, August 27, 2007-MedNet Solutions, a health care technology company specializing in clinical study management systems, has been recognized this month by both Entrepreneur magazine and Inc. magazine as one of the nation’s most rapidly growing companies. MedNet is listed as number 157 on Entrepreneur’s “Hot 500” list of entrepreneurial businesses for 2007, and number 2059 on the “Inc. 5000” list of the United States’ fastest growing private companies.
“It’s truly an honor to be named to both of these prestigious listings,” said Rob Robertson, president and chief executive officer of MedNet Solutions. “Our quick, yet controlled and profitable growth can be attributed to three important factors-the high quality of our technology offerings, the strong business partnerships we have formed with our customers, and the tremendous dedication and hard work of our staff. As our company continues to gain momentum, it’s gratifying to see our efforts paying off and to have our success recognized within the business community. We’re especially proud to be the top-ranked ‘Hot 500’ healthcare company in Minnesota-a state renowned for being a hotbed of medical technology-related organizations.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
